Old Web
English
Sign In
Acemap
>
Paper
>
O3-6-1Interim safety analysis of a phase II trial of modified-FOXFOXIRI plus bevacizumab for RAS mutant mCRC (JACCRO CC-11)
O3-6-1Interim safety analysis of a phase II trial of modified-FOXFOXIRI plus bevacizumab for RAS mutant mCRC (JACCRO CC-11)
2017
Yu Sunakawa
Hironaga Satake
Yuji Miyamoto
Masato Nakamura
Hiroshi Nakayama
Akio Higuchi
Masahiro Takeuchi
Masashi Fujii
Takashi Sekikawa
Wataru Ichikawa
Keywords:
General surgery
Bevacizumab
Medicine
Cancer research
Mutant
Oncology
Pathology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]